Eight-Member Jury for Karger Publishers’ Fourth Annual Vesalius Innovation Award Set, Submissions Closing Soon

August 25, 2023 12:00 AM AEST | By EIN Presswire

Google News:

Recent News

Secure Code Warrior Unveils Industry-First AI Coding Rulesets to Guide...

Avata Biosciences Signs Co-Development and Licensing Agreement with Oc...

Gilead Researcher Awarded the AAAS Mani L. Bhaumik Breakthrough of the...

Powering Tomorrow: PSEG Day Opens Doors for Skilled Trades Careers

BASEL, SWITZERLAND, August 24, 2023/EINPresswire.com/ -- The fourth year of the Vesalius Innovation Award, with a total of $25,000 in prizes to be granted to the top performers, has announced its list of jury members. The winner will receive $15,000, while the two runners-up will be awarded $5,000 each.

The jury members include Gabriella Karger, Chairwoman & Publisher, Karger; Professor Dr. med., Dr.med.h.c. Dan Atar, Professor of Cardiology and Head of Research, Dept. of Medicine, Oslo University Hospital; Jignesh Bhate, Founder & CEO, Molecular Connections; Stephanie Dawson, ScienceOpen CEO; Dr Phill Jones, Co-founder, Digital and Technology, MoreBrains Cooperative; Hylke Koers, Chief Information Officer, STM; Sarah Greaves,Consultant, STEM Consulting Limited; and Miki Olshansky, CEO, Elgan Pharma, Ltd.

“The satisfaction of seeing our ideas take shape and become reality has been my biggest motivation,” says Stephanie Dawson about her role as a jury member. “Each new user, customer or funder is an affirmation of that vision. I am honored to be part of the Vesalius Innovation Award to support start-ups in that process from idea to product.”

This year’s competition will focus on knowledge communication, patient centricity, and artificial intelligence. Early-stage startups in the health sciences are encouraged to submit their award applications via the dedicated website, www.karger.com/via by noon CEST on September 3, 2023.

After the jury’s evaluation, the top five shortlisted startups will be invited to present their ideas at the STM Week in London in December as an excellent opportunity for the contestants to showcase their innovations to a wider audience and gain valuable exposure.

About the Vesalius Innovation Award
The Vesalius Innovation Award has been presented in collaboration with the STM Association since its inception, and the organizers are grateful for the continued support of Gold Sponsor Molecular Connections, new Silver Sponsor Park56, alongside the new partner Silverchair.

The Vesalius Innovation Award, whose name originates from the renaissance rebel and pioneer of modern anatomy Andreas Vesalius, is an excellent opportunity for startups in the Health Sciences and Publishing sectors to gain recognition and support for their innovative ideas. Karger encourages all eligible startups to apply and wishes them the best of luck in the competition.

About Karger Publishers
Karger Publishers is a worldwide publisher of scientific and medical content based in Basel, Switzerland. It is independent and family-led in the fourth generation by Chairwoman and Publisher Gabriella Karger. Connecting and advancing health sciences since 1890, Karger has been continuously evolving, keeping pace with the current developments and shifts in research and publishing. The publishing house is dedicated to serving the information needs of the scientific community, clinicians, and patients with publications of high-quality content and services in health sciences. Karger Publishers has 240 employees and is present in 15 countries around the globe.

For more information, please visit karger.com

Christine Hohlbaum
Hohlbaum PR & Social Media
+49 177 8638661
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube
Other

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.